These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Physiopathology of eczema]. Krasteva M; Choquet G; Descotes J; Nicolas JF Rev Prat; 1998 May; 48(9):945-50. PubMed ID: 11767351 [TBL] [Abstract][Full Text] [Related]
12. Role of Langerhans cells in cutaneous immunologic processes. Dezutter-Dambuant C Semin Dermatol; 1988 Jun; 7(2):163-70. PubMed ID: 3153438 [No Abstract] [Full Text] [Related]
13. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Moll H; Fuchs H; Blank C; Röllinghoff M Eur J Immunol; 1993 Jul; 23(7):1595-601. PubMed ID: 8325337 [TBL] [Abstract][Full Text] [Related]
15. Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells. Bjercke S; Braathen L; Gaudernack G; Thorsby E Acta Derm Venereol; 1985; 65(5):374-8. PubMed ID: 2416158 [TBL] [Abstract][Full Text] [Related]
16. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction. Thorsby E; Berle E; Scott H; Braathen LR Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471 [TBL] [Abstract][Full Text] [Related]
17. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis. Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088 [TBL] [Abstract][Full Text] [Related]
18. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. Streilein JW; Grammer SF J Immunol; 1989 Dec; 143(12):3925-33. PubMed ID: 2592763 [TBL] [Abstract][Full Text] [Related]
19. Pillars article: CTLA-4 can function as a negative regulator of T cell activation. Immunity. 1994. 1: 405-413. Walunas TL; Lenschow DJ; Bakker CY; Linsley PS; Freeman GJ; Green JM; Thompson CB; Bluestone JA J Immunol; 2011 Oct; 187(7):3466-74. PubMed ID: 21934098 [No Abstract] [Full Text] [Related]
20. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Angelini G; Gardella S; Ardy M; Ciriolo MR; Filomeni G; Di Trapani G; Clarke F; Sitia R; Rubartelli A Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1491-6. PubMed ID: 11792859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]